Abstract
Human genomics is undergoing a step change from being a predominantly research-driven activity to one driven through health care as many countries in Europe now have nascent precision medicine programmes. To maximize the value of the genomic data generated, these data will need to be shared between institutions and across countries. In recognition of this challenge, 21 European countries recently signed a declaration to transnationally share data on at least 1 million human genomes by 2022. In this Roadmap, we identify the challenges of data sharing across borders and demonstrate that European research infrastructures are well-positioned to support the rapid implementation of widespread genomic data access.
Original language | English |
---|---|
Pages (from-to) | 693-701 |
Number of pages | 9 |
Journal | Nature Reviews Genetics |
Volume | 20 |
Issue number | 11 |
Early online date | 27 Aug 2019 |
DOIs | |
Publication status | Published - Nov 2019 |
Funding
E.B. is a paid consultant to Oxford Nanopore, Glaxo-SmithKline and Dovetail Inc. S.Br. acknowledges funding from the Danish Agency for Science, Technology and Innovation (09–067306), Novo Nordisk Foundation (NNF14CC0001). P.F. is a member of the scientific advisory boards of Fabric Genomics, Inc., and Eagle Genomics, Ltd. The other authors declare no competing interests.
Funders | Funder number |
---|---|
Danish Agency for Science and Higher Education | 09–067306 |
Novo Nordisk Fonden | NNF14CC0001 |